Aphria Inc. APHA APHA reported second-quarter financial results Tuesday, with net revenue of CA$120.6 million ($92.2 million), up 457% year-over-year from CA$21.7 million.
The company posted a net loss for the quarter of CA$7.9 million or CA$0.03 per share versus net income of CA$16.4 million, or CA$0.07 per share, in the first quarter.
The loss was mostly due to provisions related to Aphria’s Tier 3 passive investment portfolio, the company said.
Revenue for adult-use cannabis jumped 46% from the previous quarter to CA$29 million.
Aphria said it achieved a positive adjusted EBITDA of CA$1.9 million, up from CA$1 million in the prior quarter.
Irwim Simon will continue as CEO and is no longer working on an interim basis, according to Aphria.
Don’t miss out on the top cannabis stories of the day. Click here to sign up for our daily insider newsletter.
“We are very pleased with our strong growth and execution in Canada demonstrated by our increase in adult-use cannabis revenue and positive adjusted EBITDA as a result of our compelling brands and market positioning,” Simon said in a statement.
The company updated its guidance for fiscal year 2020, projecting net revenue between CA$575 million and CA$625 million and adjusted EBITDA of CA$35 million to CA$42 million.
Aphria shares were trading down 8.07% at $5.01 in Tuesday's premarket session.
Related Links:
Aphria Analyst Trims Price Target On Lower Sales Projections Ahead Of Q2 Report
Aurora Cannabis Analyst Lowers Price Target, Says Company Needs 'Greater Financial Discipline'
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Cannabis is evolving – don’t get left behind!
Curious about what’s next for the industry and how to leverage California’s unique market?
Join top executives, policymakers, and investors at the Benzinga Cannabis Market Spotlight in Anaheim, CA, at the House of Blues on November 12. Dive deep into the latest strategies, investment trends, and brand insights that are shaping the future of cannabis!
Get your tickets now to secure your spot and avoid last-minute price hikes.